...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Not really news but

Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2)

ClinicalTrials.gov Identifier: NCT04915300 
Recruitment Status: Not yet recruiting
Last Update Posted: April 18, 2023
  

https://clinicaltrials.gov/ct2/show/NCT04915300


Sponsors and Collaborators
Laval University
Canadian Institutes of Health Research (CIHR)
Resverlogix Corp

 

 

Koo

Share
New Message
Please login to post a reply